Fig. 4From: Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year resultsImprovement in “outer retinal thickness” according to study timepoints (T0, T1, T2) in the eye treated with WJ-MSCs (Table 1, patient 15: left eye). a Before application, 84.8 μm. b At 6th month, 120.0 μm. c At 12th month, 122.8 μmBack to article page